Vineet Talwar, DM, FRCP, DNB, FICP, FIMSA, MNAMS, discusses the utility of immunotherapy in metastatic urothelial carcinoma.
Vineet Talwar, DM, FRCP, DNB, FICP, FIMSA, MNAMS
Advertisement
Articles by Vineet Talwar, DM, FRCP, DNB, FICP, FIMSA, MNAMS
Advertisement
Latest Updated Articles
Dr. Talwar on the Utility of Immunotherapy in Metastatic Urothelial CarcinomaPublished: May 24th 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts NDA for Zanzalintinib Plus Atezolizumab in Pretreated mCRC
2
Retrospective, Real-World Analysis Shows Improved OS With Apalutamide Over Darolutamide in mCSPC
3
HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts
4
SC Daratumumab Plus VRd Expands Options in Newly Diagnosed, Transplant-Ineligible Myeloma
5